1 / 16

Inflammation

Inflammation. Dr. Ahmad Hameed MBBS,DCP, M.Phil. Chemical Mediators and regulators of inflammation. Chemical mediators that are responsible for vascular and cellular events of inflammation.

williammlewis
Télécharger la présentation

Inflammation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Inflammation Dr. Ahmad Hameed MBBS,DCP, M.Phil

  2. Chemical Mediators and regulators of inflammation • Chemical mediators that are responsible for vascular and cellular events of inflammation. • Mediators may be produced locally by cells at inflammation, or may be derived from circulating precursors (typically synthesized by the liver) that are released at the site of inflammation. • Cell-derived mediators are • Sequestered intracellular granules or synthesized de novo • Plasma derived mediators are inactive which undergo proteolytic cleavage to acquire biologic activity. • .

  3. Chemical Mediators and regulators of inflammation • Most mediators act by binding to specific receptors on different target cells. • Diverse action • Direct action • The actions of most mediators are tightly regulated and short lived • Quickly decay • Inactivated by enzymes • Eliminated • inhibited

  4. Cell-Derived Mediators Tissue macrophages, mast cells, and endothelial cells, leukocytes Vasoactive Amines HISTAMINE • Richest source • Mast cells ( C.T , B.V) • Basophils • Platelets Release in response to • Physical injury (trauma, cold, heat) • Immune reactions (Antibody to mast cells) • Anaphylatoxins (C3a & C5a)

  5. Histamine Releasing protein (H.R.P) from leucocytes • Neuropeptides (Substance P ) • Cytokines ( IL-1, IL-8) Action • Immediate transient response (main) • Dilatation of arterioles • Increase permeability of venules • Contricts large arteries • Acts on microcirculation / bind to H1 receptors on endothelial cells

  6. SEROTONIN • 5HT • Similar action • Present in platelets, enterochromaffin cells & neurons • Neurotrasmitter and regulate intestinal motility • When platelet aggregation occurs  release serotonin • Mast cells PAF  platelet aggregation

  7. Archidonic Acid Metabolites: Prostaglandins, Leukotrienes and Lipoxins Microbial Products + Mediators of Inflammation ↓ Arachidonic Acid Prostaglandins Leukotrienes

  8. AA Metabolites • Cyclooxygenase pathway • PGs are Produced by mast cells, macrophages, endothelium and others • PGE2,PGD2,PGF2α • Vasodilation • Potentiates Edema formation • Involved in pathogenesis of pain and fever • PGI2 • Produced by prostacyclinsynthase in endothelial cell • Vasodilation, Inhibits Platelet aggregation • TXA2 • Produced by Thromboxane synthase in platelets • Vasoconstriction & stimulates platelets aggregation, unstable and converts to TXB2

  9. Production of arachidonic acid metabolites and their roles in inflammation.

  10. Lipoxygenase Pathway • LTs are secreted mainly by leukocytes and chemoattractants for leukocytes. • LTA4 • LTB4 • Produced by neutrophils & some macrophages • Chemotactic agent for neutrophils • LTC4 LTD4 & LTE4 • Produced by mast cells • Vasocontriction + bronchospasm + Intravascular Permeability

  11. Anti-inflammatory Drugs that Block Prostagladin Production • NSAID • Inhibit cyclooxygenase • Prevent biosynthesis of all PG • Treat pain and fever • Cyclooxygenase inhibitor • Two isoforms - COX-1/COX-2 • COX-1 • Expressed on most tissues produced in response to inflammation stimulate prostaglandins • COX-2 • Absent most tissues • Developed that they will not affect protective function of prostaglandins • Increased risk of cerebrovascular and cardiovascular events

  12. Lipoxygenase Pathway • Lipoxins (Anti inflammatory mediators ) • Endogenous antagonists of Leukotrienesie inhibit neutrophilchemotaxis and adhesion to endothelium • Platelet adherent to neutrophils from LXA4 and LXB4

  13. Cortisol • Reduces vascular permeability and edema • Decreases prostglandin production by preventing release of AA by inhibiting phospholipase A2

  14. Platelet-Activating Factor • It is generated from a lipid complex stored in cell membranes; Produced by WBCs & endothelial cells • induces platelet aggregation; • Causes Vasoconstriction, Bronchoconstriction • It activates neutrophils and is a potent eosinophilchemoattractant; • It contributes to extravascularization of plasma proteins and so, to edema.

More Related